Dr. Michael A. Mao, MD

Dr. Mao practices at Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic.

Dr. Mao's NPI, 1720217177, was assigned on July 7, 2009. Dr. Mao graduated from Creighton University School of Medicine - Omaha in 2009. Dr. Mao holds Florida license ME138307.

Dr. Mao's primary practice is Mayo Clinic Hospital, at 4500 San Pablo Rd, Jacksonville, FL 32224 in Duval County. The practice phone is (904) 953-2000.

Dr. Mao's primary practice is Mayo Clinic Hospital in Jacksonville, Florida, part of Mayo Clinic. The medical group on file is Mayo Clinic Jacksonville. Dmand AI also links Dr. Mao to 1 more dialysis center, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mao practices, 2 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Mao's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Mao is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Mao's licenses on file in 3 states: Florida, Minnesota and Wisconsin.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances, hypercalcemia and kidney disease among the conditions Dr. Mao treats.

CMS data shows 633 Medicare services from Dr. Mao across 15 procedure codes in 2024, for 319 Medicare patients. Medicare paid $86,312 for them.

CMS counts 319 Medicare patients who saw Dr. Mao in 2024. The largest group is 65 to 74, with 125 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 8% are also on Medicaid. Their average risk score is 4.60, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mao's median patient age at 64, with 32% women.

In 2024, Dr. Mao wrote 319 Medicare Part D claims for 68 patients. 90% of them were for generic drugs. CMS names the drug for 144 of them, across 8 drugs with 11 or more claims each, at $5,630 in total drug cost. In 2023, CMS named 67 claims across 4 drugs.

Dr. Mao accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mao as offering telehealth.

Dmand AI links 190 papers to Dr. Mao, published from 2011 to 2025. 2020 was the busiest year, with 40. The most frequent topics are Acute Kidney Injury, Hospital Mortality and Kidney Transplantation. Dr. Mao has published most often in J Clin Med. Dr. Mao's most frequent co-authors are Wisit Cheungpasitporn, MD, Charat Thongprayoon, MD and Napat Leeaphorn, MD.

CMS Open Payments shows 1 general payment to Dr. Mao from 1 drug or device company in 2019. Food and beverage make up the largest share, 100% of the total. Otsuka America Pharmaceutical, Inc. paid the most, $18.

Dr. Mao graduated from Creighton University School of Medicine - Omaha in 2009.

Dr. Mao is in network with 6 carriers, including Elevance, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. POS plans come from the most carriers, 4. Check the plan with the practice before a visit.